Doctor profile · Federal record
Dr. Michael Contreras, MD
Dermatology Physician (CMS: Dermatology) · Glendale, CO
- NPI 1457367013
- Accepts Medicare
- MIPS 89.2 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4500 E Cherry Creek South Dr Ste 600
Glendale, CO 802461500
(303) 355-3000
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- January 25, 2026
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Colorado #48593
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457367013. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,132
Distinct HCPCS
10
Medicare allowed
$96,955
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 2,800 | 14 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 361 | 88 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 312 | 208 | $93 | |
17000 |
Destruction of precancer skin growth, 1 growth | 176 | 129 | $58 | |
11102 |
Biopsy of related skin growth, first growth | 108 | 93 | $97 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 78 | 66 | $58 | |
17110 |
Destruction of skin growth, 1-14 growths | 61 | 56 | $119 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 44 | 37 | $131 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 40 | 40 | $115 | |
11103 |
Biopsy of related skin growth, each additional growth | 27 | 21 | $53 |
In context: peer comparison
Among 2 peers in Glendale Dermatology Physician, average services per provider: 358. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$2,109
Transactions
58
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | 9 | $451.09 | |
| Dermavant Sciences, INC. | 7 | $263.61 | |
| Ucb, INC. | 4 | $247.12 | |
| Galderma Laboratories, L.P. | 9 | $213.63 | |
| Incyte Corporation | 5 | $171.54 | |
| Novartis Pharmaceuticals Corporation | 8 | $169.84 | |
| Pfizer INC. | 2 | $135.43 | |
| Sun Pharmaceutical Industries INC. | 2 | $102.00 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $85.41 | |
| Abbvie INC. | 3 | $70.16 | |
| Genzyme Corporation | 2 | $46.53 | |
| Regeneron Healthcare Solutions, INC. | 2 | $42.41 | |
| Janssen Biotech, INC. | 1 | $26.42 | |
| Novocure INC. | 1 | $25.86 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $22.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
164
Patients
100
Total drug cost
$3,929
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 48 | 36 | $288 |
| Clobetasol Propionate | Generic | 28 | 24 | $974 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 24 | 16 | $562 |
| Cephalexin | Generic | 14 | 12 | $128 |
| Hydrocortisone | Generic | 14 | 12 | $112 |
| Fluocinonide | Generic | 13 | 0 | $562 |
| Ketoconazole | Generic | 12 | 0 | $282 |
| Fluorouracil | Generic | 11 | 0 | $1,020 |
Frequently asked questions
What is Dr. Michael Contreras's medical specialty?
Dr. Michael Contreras practices Dermatology Physician in Glendale, CO.
Where does Dr. Michael Contreras practice?
Dr. Michael Contreras practices at 4500 E Cherry Creek South Dr Ste 600, Glendale, CO 802461500. Office phone: 3033553000.
What is Dr. Michael Contreras's NPI?
Dr. Michael Contreras's National Provider Identifier (NPI) is 1457367013, issued by NPPES.
Does Dr. Michael Contreras accept Medicare assignment?
Yes. Dr. Michael Contreras accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Contreras commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.